- Home
- BBAI vs OPK Comparison
BBAI vs OPK Comparison
Compare BBAI & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- OPK
- Stock Information
- Founded
- BBAI 2020
- OPK 2007
- Country
- BBAI United States
- OPK United States
- Employees
- BBAI N/A
- OPK N/A
- Industry
- BBAI EDP Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- OPK Health Care
- Exchange
- BBAI Nasdaq
- OPK Nasdaq
- Market Cap
- BBAI 1.1B
- OPK 1.0B
- IPO Year
- BBAI N/A
- OPK 1995
- Fundamental
- Price
- BBAI $3.92
- OPK $1.47
- Analyst Decision
- BBAI Buy
- OPK Strong Buy
- Analyst Count
- BBAI 4
- OPK 3
- Target Price
- BBAI $4.50
- OPK $2.75
- AVG Volume (30 Days)
- BBAI 51.0M
- OPK 2.9M
- Earning Date
- BBAI 03-06-2025
- OPK 02-25-2025
- Dividend Yield
- BBAI N/A
- OPK N/A
- EPS Growth
- BBAI N/A
- OPK N/A
- EPS
- BBAI N/A
- OPK N/A
- Revenue
- BBAI $154,972,000.00
- OPK $711,408,000.00
- Revenue This Year
- BBAI $13.47
- OPK N/A
- Revenue Next Year
- BBAI $16.32
- OPK $0.00
- P/E Ratio
- BBAI N/A
- OPK N/A
- Revenue Growth
- BBAI 0.01
- OPK N/A
- 52 Week Low
- BBAI $1.17
- OPK $0.86
- 52 Week High
- BBAI $5.20
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- BBAI 55.23
- OPK 44.04
- Support Level
- BBAI $2.85
- OPK $1.44
- Resistance Level
- BBAI $4.79
- OPK $1.55
- Average True Range (ATR)
- BBAI 0.55
- OPK 0.06
- MACD
- BBAI -0.07
- OPK -0.00
- Stochastic Oscillator
- BBAI 45.53
- OPK 33.33
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.